Predictive and risk factor analysis for bloodstream infection in high-risk hematological patients with febrile neutropenia: post-hoc analysis from a prospective, large-scale clinical study
Predictive and risk factor analysis for bloodstream infection in high-risk hematological patients with febrile neutropenia: post-hoc analysis from a prospective, large-scale clinical study
复制标题
发热性中性粒细胞减少症高危血液病患者血流感染的预测和危险因素分析:来自前瞻性大规模临床研究的事后分析
DOI:
10.1007/s12185-021-03183-x
复制
发表时间:
2021
影响因子:
2.1
通讯作者:
from the Japan Febrile Neutropenia Study Group
中科院分区:
文献类型:
--
作者:
Okamoto Akinao;Kanda Yoshinobu;Kimura Shun-ichi;Oyake Tatsuo;Tamura Kazuo;from the Japan Febrile Neutropenia Study Group
ObjectivesBloodstream infection (BSI) is a frequent complication observed in patients with febrile neutropenia (FN). BSI risk factors and incidence vary depending on chemotherapy types and prophylactic antimicrobial agents. We clarified these issues by post-hoc analysis of a prospective clinical trial cohort for severe FN in hematological malignancy.MethodsWe performed an intention-to-treat analysis of 413 high-risk patients and 1272 blood culture sets.ResultsOverall, 356 patients (86.2%) developed FN, and 20.8% had BSI complications. Prophylactic antimicrobials did not prevent complications of FN and BSI, but the incidence of BSIs of Gram-negative (GN) bacteria was lower than in the non-prophylaxis group (23.8% vs. 56.7%). Multinational Association of Supportive Care in Cancer (MASCC) scores < 20 were significantly correlated with the incidence of BSI, whereas MASCC scores > 21 were not (41.7% vs. 17.2%). The only significant risk factors were hypotension and dehydration. axillary temperatures were higher in GN-caused BSIs than in Gram-positive-caused BSIs and in patients with negative blood culture results (38.7 °C vs. 38.2 °C vs. 38.0 °C). The higher the fever, the higher the incidence of BSI and GN bacteremia.ConclusionsMASCC score and axillary temperature are strong predictors of BSI. Non-administration of prophylactic antimicrobials and GN-caused BSI are correlated.The clinical trial registration numberUMIN00010411.
登录
查看更多内容
影响因子:
45.3
作者:
Klastersky, J;Paesmans, M;Talcott, J
通讯作者:
Talcott, J
影响因子:
3.7
作者:
Aziz Hamadah;Y. Schreiber;B. Toye;S. Mcdiarmid;L. Huebsch;C. Bredeson;J. Tay
通讯作者:
J. Tay
影响因子:
--
作者:
Taplitz, Randy A.;Kennedy, Erin B.;Flowers, Christopher R.
通讯作者:
Flowers, Christopher R.
影响因子:
3.1
作者:
Combariza, Juan F.;Lombana, Milton;Arango, Marcos
通讯作者:
Arango, Marcos
影响因子:
4.8
作者:
J. Pérez;I. Garcia;J. Martínez;L. Vázquez;D. Caballero;C. Cañizo;M. Mateos;J. S. Miguel
通讯作者:
J. S. Miguel